Literature DB >> 15908346

Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis.

Bryan Coburn1, Yuling Li, David Owen, Bruce A Vallance, B Brett Finlay.   

Abstract

Salmonella species cause a wide range of disease in multiple hosts. Salmonella enterica serovar Typhimurium causes self-limited intestinal disease in humans and systemic typhoid-like illness in susceptible mice. The prevailing dogma in murine S. enterica serovar Typhimurium pathogenesis is that distinct virulence mechanisms-Salmonella pathogenicity islands 1 and 2 (SPI1 and SPI2)-perform distinct roles in pathogenesis, the former being important for invasion and intestinal disease and the latter important for intracellular survival and systemic persistence and disease. Although evidence from bovine infections has suggested that SPI2 has a role in ileal disease, there is no evidence that SPI2 is important for inflammation in a disease that more closely recapitulates human colitis. Using S. enterica serovar Typhimurium strains that lack functional type III secretion systems, we demonstrate that SPI2 is essential for complete virulence in murine infectious enterocolitis. Using a recently characterized murine model (M. Barthel,S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt, Infect. Immun. 71:2839-2858, 2003), we demonstrate that SPI1 mutants are unable to cause intestinal disease 48 h after infection and that SPI2-deficient bacteria also cause significantly attenuated typhlitis. We show that at the peak of inflammation in the cecum, SPI2 mutants induce diminished intercellular adhesion molecule 1 expression and neutrophil recruitment but that wild-type and mutant Salmonella are similarly distributed in the lumen of the infected organ. Finally, we demonstrate that attenuation of intestinal inflammation is accompanied by resolution of typhlitis in the mutant, but not wild-type, infections. Collectively, these results indicate that SPI2 is needed for enterocolitis, as well as for systemic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908346      PMCID: PMC1111876          DOI: 10.1128/IAI.73.6.3219-3227.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Molecular basis of Salmonella-induced enteritis.

Authors:  T S Wallis; E E Galyov
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

Review 2.  Animal models of Salmonella infections: enteritis versus typhoid fever.

Authors:  R L Santos; S Zhang; R M Tsolis; R A Kingsley; L G Adams; A J Bäumler
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

3.  Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves.

Authors:  R M Tsolis; L G Adams; T A Ficht; A J Bäumler
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  SifA permits survival and replication of Salmonella typhimurium in murine macrophages.

Authors:  J H Brumell; C M Rosenberger; G T Gotto; S L Marcus; B B Finlay
Journal:  Cell Microbiol       Date:  2001-02       Impact factor: 3.715

5.  The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms.

Authors:  Siegfried Hapfelmeier; Bärbel Stecher; Manja Barthel; Marcus Kremer; Andreas J Müller; Mathias Heikenwalder; Thomas Stallmach; Michael Hensel; Klaus Pfeffer; Shizuo Akira; Wolf-Dietrich Hardt
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Disruption of the Nramp1 (also known as Slc11a1) gene in Kupffer cells attenuates early-phase, warm ischemia-reperfusion injury in the mouse liver.

Authors:  Samuel Wyllie; Philip Seu; Feng Qin Gao; Phillippe Gros; John A Goss
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

8.  Salmonella pathogenicity island 2 influences both systemic salmonellosis and Salmonella-induced enteritis in calves.

Authors:  J Bispham; B N Tripathi; P R Watson; T S Wallis
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase.

Authors:  A Vazquez-Torres; Y Xu; J Jones-Carson; D W Holden; S M Lucia; M C Dinauer; P Mastroeni; F C Fang
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

10.  Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis.

Authors:  P Everest; J Ketley; S Hardy; G Douce; S Khan; J Shea; D Holden; D Maskell; G Dougan
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

View more
  99 in total

1.  Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model.

Authors:  Kaoru Geddes; Stephen Rubino; Catherine Streutker; Joon Ho Cho; Joao G Magalhaes; Lionel Le Bourhis; Thirumahal Selvanantham; Stephen E Girardin; Dana J Philpott
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Small intestinal intraepithelial lymphocytes expressing CD8 and T cell receptor γδ are involved in bacterial clearance during Salmonella enterica serovar Typhimurium infection.

Authors:  Zhiyuan Li; Cai Zhang; Zhixia Zhou; Jianhua Zhang; Jian Zhang; Zhigang Tian
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Integration of a complex regulatory cascade involving the SirA/BarA and Csr global regulatory systems that controls expression of the Salmonella SPI-1 and SPI-2 virulence regulons through HilD.

Authors:  Luary C Martínez; Helen Yakhnin; Martha I Camacho; Dimitris Georgellis; Paul Babitzke; José L Puente; Víctor H Bustamante
Journal:  Mol Microbiol       Date:  2011-05-12       Impact factor: 3.501

Review 4.  Taming the elephant: Salmonella biology, pathogenesis, and prevention.

Authors:  Helene L Andrews-Polymenis; Andreas J Bäumler; Beth A McCormick; Ferric C Fang
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

5.  Diarrhea and colitis in mice require the Salmonella pathogenicity island 2-encoded secretion function but not SifA or Spv effectors.

Authors:  Joshua Fierer; Sharon Okamoto; Ananya Banerjee; Donald G Guiney
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 6.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 7.  How flagellin and toll-like receptor 5 contribute to enteric infection.

Authors:  Theodore S Steiner
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

8.  Salmonella enterica Effectors SifA, SpvB, SseF, SseJ, and SteA Contribute to Type III Secretion System 1-Independent Inflammation in a Streptomycin-Pretreated Mouse Model of Colitis.

Authors:  Shigeki Matsuda; Takeshi Haneda; Hiyori Saito; Tsuyoshi Miki; Nobuhiko Okada
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

9.  IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.

Authors:  Timothy J Bauler; Jennifer C Chase; Catharine M Bosio
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

10.  Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies.

Authors:  Kelsey E Sivick; Nicholas Arpaia; Gabrielle L Reiner; Bettina L Lee; Bethany R Russell; Gregory M Barton
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.